Dynavax Technologies | Attività Correnti

Current Assets Cambiamento Data
AbbVie USD 33.22B 4.37B 2023-09
Adma Biologics USD 257.01M 16.69M 2023-12
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Dynavax Technologies USD 859.12M 23.45M 2023-12
Gilead Sciences USD 16.45B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
TG Therapeutics USD 319.11M 110.54M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Dynavax Technologies Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.